Sosei Heptares and Captor Therapeutics Enter Strategic Technology Collaboration Focused on Targeted GPCR Degradation as Novel Approach for Drug Design ...Middle East

TOKYO and CAMBRIDGE, England, Dec. 22, 2020 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565), a world leader in GPCR-focused structure-based drug design and development, and Captor Therapeutics SA ("Captor"; Wroclaw, Poland and Allschwil, Switzerland), a European leader...

Hence then, the article about sosei heptares and captor therapeutics enter strategic technology collaboration focused on targeted gpcr degradation as novel approach for drug design was published today ( Tuesday 22/12/2020 - 12:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sosei Heptares and Captor Therapeutics Enter Strategic Technology Collaboration Focused on Targeted GPCR Degradation as Novel Approach for Drug Design )

Also on site :

• Neymar's Steam profile flooded with Norwegian flags after FIFA World Cup 2026 exit
• Super typhoon smacks into US Pacific island territories home to key military bases
• "Smuggle chainsaws onto the pitch": What Blood Bowl's new publisher thinks the World Cup can learn from Warhammer